These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 468497)

  • 1. Sequential changes in the CT numbers of the normal canine kidney following intravenous contrast administration. II: The renal medulla.
    Brennan RE; Curtis JA; Pollack HM; Weinberg I
    Invest Radiol; 1979; 14(3):239-45. PubMed ID: 468497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential changes in the CT numbers of the normal canine kidney following intravenous contrast administration. I. The renal cortex.
    Brennan RE; Curtis JA; Pollack HM; Weinberg I
    Invest Radiol; 1979; 14(2):141-8. PubMed ID: 478803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of contrast media: experimental results in dog and man with CT implications.
    Gardeur D; Lautrou J; Millard JC; Berger N; Metzger J
    J Comput Assist Tomogr; 1980 Apr; 4(2):178-85. PubMed ID: 7365016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT-determined canine kidney and urine iodine concentration following intravenous administration of sodium diatrizoate, metrizamide, iopamidol, and sodium ioxaglate.
    Brennan RE; Rapoport S; Weinberg I; Pollack HM; Curtis JA
    Invest Radiol; 1982; 17(1):95-100. PubMed ID: 7076442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiphasic renal CT: comparison of renal mass enhancement during the corticomedullary and nephrographic phases.
    Birnbaum BA; Jacobs JE; Ramchandani P
    Radiology; 1996 Sep; 200(3):753-8. PubMed ID: 8756927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-density evaluation of the liver after iosulamide meglumine: a tissue-specific CT contrast agent.
    Marincek B; Young SW; Enzmann DR
    Invest Radiol; 1982; 17(1):90-4. PubMed ID: 7076441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomes loaded with contrast material for image enhancement in computed tomography. Work in progress.
    Ryan PJ; Davis MA; DeGaeta LR; Woda B; Melchior DL
    Radiology; 1984 Sep; 152(3):759-62. PubMed ID: 6611564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of contrast medium dose and image acquisition timing on ureteral opacification in the normal dog as assessed by computed tomography.
    Barthez PY; Begon D; Delisle F
    Vet Radiol Ultrasound; 1998; 39(6):524-7. PubMed ID: 9845189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast and electrolyte dynamics of the intravenous pyelogram. II. Disparities in serum and urine concentrations of meglumine and anion.
    Lasser EC; Lang JH; Hamblin AE; Rosen L
    Invest Radiol; 1975; 10(4):307-13. PubMed ID: 1184320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic hepatic CT: uniphasic and biphasic contrast medium injection protocols.
    Drop A
    Ann Univ Mariae Curie Sklodowska Med; 1999; 54():195-204. PubMed ID: 11205764
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiographic measurement of renal compartments. Corticomedullary ratio in normal, diseased states and sickle cell anemia.
    Khademi M
    Radiology; 1974 Oct; 113(1):51-8. PubMed ID: 4422796
    [No Abstract]   [Full Text] [Related]  

  • 12. Iopamidol in urography. A comparison between ionic and nonionic contrast media in patients with normal and impaired renal function.
    Dalla Palma L; Rossi M; Stacul F; Agostini R
    Urol Radiol; 1982; 4(1):1-3. PubMed ID: 7101596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why does kidney size change during I.V. urography?
    Dorph S; Sovak M; Talner LB; Rosen L
    Invest Radiol; 1977; 12(3):246-50. PubMed ID: 863628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doses of contrast media.
    Davies P
    Lancet; 1978 Mar; 1(8063):556-7. PubMed ID: 76097
    [No Abstract]   [Full Text] [Related]  

  • 15. AUR Memorial Award 1990. The physiologic basis of the radiodense renal medulla after the administration of blood pool contrast agent PFOB.
    Coley BD; Mattrey RF; Mitten RM; Peterson T
    Invest Radiol; 1990 Dec; 25(12):1287-93. PubMed ID: 2279907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic enhancement and metastatic lesion conspicuity on CT scans: influence of intravenous glucagon and oral CT contrast material.
    Warshauer DM; Wehmueller MD; Molina PL; Muller KE; DeLuca MC; Lee JK
    Radiology; 1997 Feb; 202(2):394-8. PubMed ID: 9015064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxygen free radical involvement in urinary Tamm-Horsfall protein excretion after intrarenal injection of contrast medium.
    Bakris GL; Gaber AO; Jones JD
    Radiology; 1990 Apr; 175(1):57-60. PubMed ID: 2315505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast bolus dynamic computed tomography for the measurement of solid organ perfusion.
    Blomley MJ; Coulden R; Bufkin C; Lipton MJ; Dawson P
    Invest Radiol; 1993 Nov; 28 Suppl 5():S72-7; discussion S78. PubMed ID: 8282508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast media for computer tomography of the liver.
    Wegener OH; Mützel W; Souchon R
    Acta Radiol Diagn (Stockh); 1980; 21(2A):239-47. PubMed ID: 7424559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CT method for visualization of the appendix using a fixed oral dosage of diatrizoate--clinical experience in 525 cases.
    Giuliano V; Giuliano C; Pinto F; Scaglione M
    Emerg Radiol; 2005 Jul; 11(5):281-5. PubMed ID: 16133622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.